Literature DB >> 27310885

Treatment of Fuchs Endothelial Dystrophy by Descemet Stripping Without Endothelial Keratoplasty.

Durga S Borkar1, Peter Veldman, Kathryn A Colby.   

Abstract

PURPOSE: To evaluate the effect of deliberate removal of the central Descemet membrane on endothelial function and morphology in patients with Fuchs endothelial dystrophy (FED) and cataract undergoing phacoemulsification.
METHODS: In this retrospective case series, patients with FED and visually significant cataract underwent phacoemulsification in an academic cornea practice in Boston, MA. Four millimeters of the central Descemet membrane was stripped and removed after intraocular lens insertion. Vision, corneal pachymetry, and confocal imaging of the endothelial anatomy were performed before surgery and at 1, 3, 6, and 12 months after surgery. Patients were classified as fast responders, responders, slow responders, and nonresponders on the basis of postoperative time to resolution of corneal edema with visible central endothelial mosaic.
RESULTS: Eleven patients (13 eyes) aged 51 to 91 years were included in the study. No eyes had countable central endothelial cells by confocal imaging before surgery. Preoperative visual acuity ranged from 20/25 to 20/400. All corneas showed stromal and microcystic edema in the area of Descemet stripping at days 1 and 7 after surgery. Four eyes demonstrated resolution of corneal edema with visible central endothelial cell mosaic (range: 410-864 cells/mm) by postoperative month 1 with visual acuity ranging between 20/25 and 20/40. Four additional eyes demonstrated a similar response by postoperative month 3 and an additional 2 eyes had resolution of corneal edema with an intact central endothelial mosaic at postoperative month 6 or later. Cell counts (range: 428-864 cells/mm) were maintained in all 10 responders at the last follow-up visit (range: postoperative months 6-24). Final vision ranged from 20/15 to 20/20 in these 10 eyes with the exception of 2 eyes with retinal pathology. Three eyes required endothelial keratoplasty.
CONCLUSIONS: Repopulation of the central corneal endothelium with corneal deturgescence can occur after deliberate central Descemet stripping in patients with FED who underwent cataract removal. This may offer a novel treatment for patients with FED that could reduce the need for endothelial transplantation. Further studies are needed to delineate the optimal patient population for Descemet stripping because not all patients will respond to this intervention.

Entities:  

Mesh:

Year:  2016        PMID: 27310885     DOI: 10.1097/ICO.0000000000000915

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  28 in total

1.  Peripheral Endothelial Cell Count Is a Predictor of Disease Severity in Advanced Fuchs Endothelial Corneal Dystrophy.

Authors:  Zeba A Syed; Jennifer A Tran; Ula V Jurkunas
Journal:  Cornea       Date:  2017-10       Impact factor: 2.651

2.  Donor, Recipient, and Operative Factors Associated with Graft Success in the Cornea Preservation Time Study.

Authors:  Mark A Terry; Anthony J Aldave; Loretta B Szczotka-Flynn; Wendi Liang; Allison R Ayala; Maureen G Maguire; Christopher Croasdale; Yassine J Daoud; Steven P Dunn; Caroline K Hoover; Marian S Macsai; Thomas F Mauger; Sudeep Pramanik; George O D Rosenwasser; Jennifer Rose-Nussbaumer; R Doyle Stulting; Alan Sugar; Elmer Y Tu; David D Verdier; Sonia H Yoo; Jonathan H Lass
Journal:  Ophthalmology       Date:  2018-08-09       Impact factor: 12.079

3.  Donor, Recipient, and Operative Factors Associated With Increased Endothelial Cell Loss in the Cornea Preservation Time Study.

Authors:  Jonathan H Lass; Beth Ann Benetz; Sanjay V Patel; Loretta B Szczotka-Flynn; Robert O'Brien; Allison R Ayala; Maureen G Maguire; Yassine J Daoud; Mark A Greiner; Sadeer B Hannush; W Barry Lee; Thomas F Mauger; Harry J Menegay; Mark D Mifflin; Michael B Raizman; Jennifer Rose-Nussbaumer; Robert L Schultze; Gregory A Schmidt; Alan Sugar; Mark A Terry; David D Verdier
Journal:  JAMA Ophthalmol       Date:  2019-02-01       Impact factor: 7.389

Review 4.  Revisiting Existing Evidence of Corneal Endothelial Progenitors and Their Potential Therapeutic Applications in Corneal Endothelial Dysfunction.

Authors:  Yaa-Jyuhn J Meir; Hung-Chi Chen; Chien-Chang Chen; Hui-Kang D Ma
Journal:  Adv Ther       Date:  2020-01-30       Impact factor: 3.845

Review 5.  Descemet Stripping Only for a Chronic Descemet Detachment After Cataract Surgery.

Authors:  Kristin E Hirabayashi; David Mark; Jackson Lau; Charles C Lin
Journal:  Cornea       Date:  2020-03       Impact factor: 2.651

6.  Scheimpflug Corneal Densitometry Values and Severity of Guttae in Relation to Visual Acuity in Fuchs Endothelial Corneal Dystrophy.

Authors:  Khushali Shah; Allen O Eghrari; Elizabeth A Vanner; Terrence P O'Brien; Ellen H Koo
Journal:  Cornea       Date:  2021-06-15       Impact factor: 3.152

Review 7.  Phacoemulsification in the Setting of Corneal Endotheliopathies: A Review.

Authors:  Victoria S Chang; Allister Gibbons; Carla Osigian
Journal:  Int Ophthalmol Clin       Date:  2020

Review 8.  Fuchs endothelial corneal dystrophy: The vicious cycle of Fuchs pathogenesis.

Authors:  Stephan Ong Tone; Viridiana Kocaba; Myriam Böhm; Adam Wylegala; Tomas L White; Ula V Jurkunas
Journal:  Prog Retin Eye Res       Date:  2020-05-08       Impact factor: 21.198

Review 9.  Regenerative medicine in Fuchs' endothelial corneal dystrophy.

Authors:  Amy E Yuan; Roberto Pineda
Journal:  Taiwan J Ophthalmol       Date:  2020-07-06

Review 10.  New Horizons in the Treatment of Corneal Endothelial Dysfunction.

Authors:  Carlos Rocha-de-Lossada; Rahul Rachwani-Anil; Davide Borroni; José-María Sánchez-González; Raquel Esteves-Marques; Fernando-Luis Soler-Ferrández; Jose-Antonio Gegúndez-Fernández; Vito Romano; Eitan Livny; Marina Rodríguez Calvo-de-Mora
Journal:  J Ophthalmol       Date:  2021-07-09       Impact factor: 1.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.